Research / CLAR / Fundamental state Inspectable configuration
State dimensions Filing 0001558370-24-002739 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
41.88% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
11.16% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-36.17% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
31.96% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
34.09% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-7.38% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.45% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.85% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 17 states Self-history eligible
Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/7 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 0/9 normalized Level 3 Mar 31, 2024 0/8 normalized Level 3 Jun 30, 2024 6/7 normalized Level 3 Sep 30, 2024 6/7 normalized Level 3 Dec 31, 2024 7/9 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/9 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 122.55%
Current 41.88%
Delta -80.67% Capex Intensity Increased
Previous 1.24%
Current 2.00%
Delta 0.76% Cash Generation Increased
Previous 0.14%
Current 11.16%
Delta 11.02% Growth Decreased
Previous -13.52%
Current -36.17%
Delta -22.66% Inventory Pressure Decreased
Previous 140.35%
Current 31.96%
Delta -108.40% Margin Decreased
Previous 35.52%
Current 34.09%
Delta -1.43% Profitability Decreased
Previous 1.82%
Current -7.38%
Delta -9.20% Sbc Intensity Increased
Previous 1.17%
Current 1.85%
Delta 0.68% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.